Title
Candidate antigens for a ductal carcinoma in situ vaccine, essential for breast cancer cell survival across multiple subtypes, are immunogenic in DCIS and IBC
Document Type
Presentation
Publication Date
9-9-2022
Keywords
oregon; portland; chiles; genomics
Clinical Institute
Cancer
Department
Oncology
Recommended Citation
Sanborn, SE, "Candidate antigens for a ductal carcinoma in situ vaccine, essential for breast cancer cell survival across multiple subtypes, are immunogenic in DCIS and IBC" (2022). Articles, Abstracts, and Reports. 6987.
https://digitalcommons.providence.org/publications/6987
Comments
AACR Annual Meeting; 2022 September 9; Philadelphia, PA.